| Literature DB >> 34728591 |
Ramisetti Rajeev1, Ambey Prasad Dwivedi, Anunay Sinha, Viplove Agarwaal, Rachana Roshan Dev, Anjana Kar, Sanjeev Khosla.
Abstract
The interaction of microbiota with its host has the ability to alter the cellular functions of both, through several mechanisms. Recent work, from many laboratories including our own, has shown that epigenetic mechanisms play an important role in the alteration of these cellular functions. Epigenetics broadly refers to change in the phenotype without a corresponding change in the DNA sequence. This change is usually brought by epigenetic modifications of the DNA itself, the histone proteins associated with the DNA in the chromatin, non-coding RNA or the modifications of the transcribed RNA. These modifications, also known as epigenetic code, do not change the DNA sequence but alter the expression level of specific genes. Microorganisms seem to have learned how to modify the host epigenetic code and modulate the host transcriptome in their favour. In this review, we explore the literature that describes the epigenetic interaction of bacteria, fungi and viruses, with their mammalian hosts.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34728591 PMCID: PMC8550911
Source DB: PubMed Journal: J Biosci ISSN: 0250-5991 Impact factor: 1.826
Figure 1Histone post translational modifications (PTMs): Histone are modified at specific residues in their N-terminal tails (A) and by specific histone modifiers (B). (A) Summary of post-translationally modified amino acids in the various histone proteins. Globular core region of each histone is depicted by black rectangle. The amino acids in their N-terminal tails are depicted by 1-letter codes. PTMs are depicted above the 1-letter codes of amino acids. The numbers below depict the position of the modified amino acids from the N-terminus. The modified amino acids in the core regions of the histone are shown in green. Ac—acetylation, me—methylation, P—phosphorylation. (B) Changes in the molecular structure of amino acids by histone modifying enzymes. Acetylation: acetyl group added to terminal nitrogen atom in lysine by histone acetyltransferases (HATs). Phosphorylation: phosphate moiety is added to the hydroxyl group of α-carbon in serine and threonine and to the para-hydroxyl group in tyrosine by kinases. Methylation: methyl group(s) is (are) added to the terminal amino group of lysine or arginine by lysine methyltransferases (KMTs) or protein arginine methyltransferases (PRMTs) respectively. Up to 3 methyl groups can be added to lysine (mono- or di- or trimethyl lysine). And 2 to arginine (mono- or di-methylarginine). The two methyl groups in dimethylarginine if added at the adjacent nitrogen atom forms symmetric dimethylarginine, whereas if added to same nitrogen atoms leads to asymmetric dimethylarginine. A few known examples of histone modifying enzymes are provided for each type of modifications.
Figure 2DNA methylation. Cytosine and Adenine methylation. Cytosine is methylated at the 5th carbon whereas Adenine is methylated at the 6th carbon of the nitrogenous base. m5C—5-methylcytosine, hm5C—5-hydroxymethylcytosine, m6A—N6-Methyladenosine. A representative DNA sequence is provided. DNMTs –DNA methyltransferases; TET—an enzyme belonging to the hydroxy-methyltransferase family. Dam methylase- DNA adenine methyltransferase (known in prokaryotes).
Figure 3Modified RNA bases. Epigenetic modifications of mRNA or rRNA molecules. Methyl and hydroxyl group are added to the nitrogenous bases of either cytosines or adenine. m1A—N1-methyladenosine, m6A—N6-Methyladenosine, m6Am—N6,2-O-dimethyladenosine, m5C—5-methylcytosine, hm5C—5-hydroxymethylcytosine, 2′-O-me—2′-O-Methylation, CH3—methyl group, OH—Hydroxyl group.
Bacterial interaction with host epigenetic machinery
| Bacterial species | Bacterial factor | Nature of bacterial factor | Target molecule/gene | Downstream effects | References |
|---|---|---|---|---|---|
| Secondary metabolite | Histone deacetylase inhibitor | HDAC | HDAC mediated gene expression modulation | Varghese | |
| Aerolysin | Pore forming protein | H3 | Phosphorylation of H3S10 | Hamon and Cossart ( | |
| SCFA (acetic, propionic, butyric acids) | HDAC, HDAC3 | Affects phagocytosis and cytokine production | Naqvi | ||
| miRNA-29b and let-7f | Modulate IL-6Ra and SOCS4 at protein level | Corrêa | |||
| Lethal toxin (LT) | MAPK signalling inhibitor | IL-8 promoter | Downregulation of H3S10ph and H3K14ac | Raymond | |
| IL1-β enhancer | HDAC8 mediated deacetylation of H3K27ac | Ha | |||
| Baset ( | Histone methyltransferase | H1 | H1 lysine trimethylation | Mujtaba | |
| H3 | Phosphorylation/ Acetylation. Induction of inflammatory signalling cascade | Haller | |||
| Maintenance of homeostasis via TGFβ1/ Smad signalling and regulation of NF-kB signalling | Haller | ||||
| S-Adenosyl-L methionine(SAM) | methyl donor | Inhibition of human colon cancer cell proliferation | Pompei | ||
| H3, H4 | Reduction of global histone H4ac and H3S10/K14ac. Increased DNA methylation | Ghadimi | |||
| Bbset17 | Histone methyltransferase | Ribosomal RNA transcription dysregulation | Li | ||
| Btset | Histone Methyltransferase | H3 | Targeting H3K4 at ribosomal DNA promoter | Li | |
| Downregulation of DNMT3B, HDAC1, and HDAC2 | Krishnananthasivam | ||||
| Change in DNA methylation | Cizmeci | ||||
| Hypermethylation at promoter region of 65 genes including | Bobetsis | ||||
| Nuclear effector (NUE) | Histone methyltransferase | H2B, H3, and H4 (in vitro) | Unidentified | Pennini | |
| Cpnset | Histone methyltransferase | H3 | Unidentified | Murata | |
| Sinc | Chromatin anchoring modulator | MAN1, LAMP1 | Plausibly reorganizing the chromatin by interacting with host nuclear inner membrane protein | Mojica | |
| Aberrant CpG island methylation and E-cadherin(CDH1) gene hypermethylation | Choung | ||||
| Bont | Neurotoxin | HDAC4 | Worton | ||
| Ank200 (p200) | Transcriptional and translational modulator | AT-rich Alu-Sx elements | Dysregulation of cytoskeletal rearrangement, immune response and cell signalling genes | Zhu | |
| TRP32 | Epigenetic modulators | G-rich and G+C-rich motifs | Binds to chromatin-remodeling complexes, polycomb-group (PcG) proteins, and histone modifiers | Wakeel | |
| TRP120 | Polyubiquitinating agent | RING domain of PCGF5 | Degradation of PCGF leads to reduction in H2AK119Ub eventually activation of target gene | Mitra | |
| TRP47 | Chromatin anchor | G+C-rich motifs | Modulation of cellular signalling | Kibler | |
| membrane vesicles (MVs) | H3 | Upregulation of genes showing increased H3K4me3 at transcription start sites | Vdovikova | ||
| Butyrate | HDAC inhibitor | H3 | Increased acetylation at Foxp3 promoter | Paul | |
| miRNA-92a | Decreased proliferation and increased apoptosis | Paul | |||
| DNMT1,HDAC1,HDAC2 | Upregulates CC chemokine ligand 20 (CCL20) and β-defensin2 levels | Yin and Chung ( | |||
| CCL20, Hbd2 | Induction by acetylation and methylation | Yin and Chung ( | |||
| Histone modification | Upregulation of H2AFY, PRMT7, HDAC3 and downregulation of CXXC1, PHF8, IGF2, SUV39H1 | Yin and Chung ( | |||
| HP0175 | Peptidyl-prolyl cis-, trans isomerase(ppiase) | TLR4 | Increase in chemokine and cytokine production | Pathak | |
| H3S10ph, H3T3ph, H3K23ac, p65 | Pre-mitotic arrest by deregulating VRK1 | Pathak | |||
| HP986 and JHP0290(homolog HP0175) | 5mC at CpG islands | Induces apoptosis and TNFα release | Pathak | ||
| miRNA genes, the E-cadherin (CDH165), DNA repair (MLH166), tumor suppressor (USF1/2, WWOX) | Ando | ||||
| H3, H4 | Reduced global histone Ac-H4 and H3S10/H3K14ac, DNA methylation | Ghadimi | |||
| miRNA-155 | Downregulation of p38 | Giahi | |||
| Lpset/legas417 | Histone methyltransferase | H3 | Alteration of rRNA expression by interacting with HP1 and promoter H3K4me2 | Li | |
| Roma | Histone methyltransferase | H3 | Catalyses H3K14me3 in the nucleoplasm targeting innate immunity genes | Rolando | |
| Snpl | Transcriptional regulator | mRNA, DSIF complex (SUPT5H) | Intereferes with transcriptional process by changing RNA Pol II activity | Schuelein | |
| Ankh | Transcriptional regulator | LARP7 (snrnp complex) | Interferes with RNA pol II transcription elongation activity | Von Dwingelo | |
| Listeriolysin (LLO) | Pore-forming cytolysin | H3, H4, H2AX | Dephosphorylation of H3S10ph, deacetylation of H4 at the CXCL2 promoter, phosphorylation of H2AX | Hamon | |
| Internalin B (inlb) | Hepatocyte growth factor | H3 | Activated of PI3K – AKT pathway leading to increased SIRT2 mediated H3K18ac deacetylation at TSS | Eskandarian | |
| Listeria nuclear-targeted protein A (lnta) | BAHD, HDAC1/2 | Deacetylation and upregulation of Interferon-Stimulated gene (ISG) promoter | Bierne | ||
| Orfx | RYBP | Survival advantage by regulation of superoxide and nitric oxide production | Prokop | ||
| H3 | Induction of H3S10ph/H3K14ac combinatorial modulation by inflammatory signalling cascades | Slevogt | |||
| Rv1988 | Histone methyltransferase | H3 | Histone H3R42 methylation. Suppression of host defence genes | Yaseen | |
| Rv3423.1 | Histone acetyltransferase | Modulation of anti-inflammatory host genes | Jose | ||
| Rv2416c (EIS) | Histone acetyltransferase | H3 | Acetylation of H3 at IL-10 promoter. Helps | Duan | |
| Rv2966c | DNA methyltransferase | H3, H4 | Sharma | ||
| Cytosine | Genome-wide non-CpG methylation in the host genome | Sharma | |||
| Hsa-mir-21 | Inhibition of vitamin D–dependent antimicrobial peptides, CAMP and DEFB4A | Liu | |||
| Gc-HDAC | Histone deacetylase | H3 | Modification of host chromatin at H3K9ac mark in the promoter region | Zughaier | |
| Mir-146a | Suppression of immune response and increase bacterial survival | Zughaier | |||
| H3, DNMT1, HDAC1,KDM5B, KDM3C,p300 | Induces pro-inflammatory cytokines and Alzheimer's disease-linked gene | Imai | |||
| miRNA-128, miRNA-146, miRNA203 | Regulation of the innate immune system | Moffatt and Lamont ( | |||
| miRNA-584 | Targets the lactoferrin receptor (lfr) mRNA | Olsen | |||
| miRNA-146a, miRNA-146a-5p | Increased secretion of IL-1ß, IL-6, and TNF-a | Olsen | |||
| miRNA-128 | Mediation of endotoxin tolerance by alteration of the p38 MAPK pathway | Olsen | |||
| Spvc | Phosphatase | MAP kinase ERK1/2 TEY motif | Reduction of IL-8 and TNF-α production | Mazurkiewicz | |
| AAC (60)-ly | Histone Acetyltransferase | Histone proteins | Interferes with host transcriptional regulation | Hamon and Cossart ( | |
| MTR4, RRP6 | Accumulation of unstable nuclear ncRNAs and upregulation of immune genes | Imamura | |||
| miRNA-155, let-7 | Increase in IL-6 and IL-10 | Schulte | |||
| Ospf | Phosphothreonine lyase | MAPK (p38 and ERK) | Abrogation of H3S10 phosphorylation at NF-kb regulated promoters | Arbibe | |
| HP1 | Dephosphorylation of HP1S83, by inactivation of kinase MSK1 | Arbibe | |||
| miRNA-155, miRNA-31 | MTOR-dependent upregulation. Regulation of PP2A | Holla | |||
| miRNA-29b-2-5p | Increased intracellular replication of Shigella | Grassl and Finlay ( | |||
| Pneumolysin (PLY) | Pore forming protein | H3 | Dephosphorylation of histone H3S10 | Dong | |
| miRNA-200b | Pneumonia via targeting of KALRN | Huang | |||
| 2-aminoacetophenone | Quorum-sensing signal metabolite | HDAC1 | Global hypoacetylation of histone H3K18 | Bandyopadhaya | |
| Popb, popd | Phosphatase | H3 | Indirect dephosphorylation of H3S10 | Dortet | |
| miRNA-93 | Post-transcriptionally regulates IL-8 protein | Dortet |
Figure 4Epigenetic interaction of microbes with host cell. A cartoon depicting multiple ways by which microbe-host cell interaction can influences host epigenetic circuitry. (i) Modulation of chromatin organisation through interaction of the microbe (extracellular) with the host receptor that activates signalling cascade(s). (ii) Release of factors by extracellular or intracellular microbe in the host cells can that can interact with host factors having capability of modulating chromatin conformation. (iii) Secretion of microbial factors in the extracellular or intracellular milieu which upon entry into host cell nucleus interact directly with the chromatin directly. All these pathways individually or in concert can change both histone modifications and DNA methylation leading to changes in the chromatin conformation.